Impax hires new compliance officer; MIT continuous manufacturing start-up gets new home;

> Impax Laboratories ($IXPL) has named Deborah M. Penza, an Actavis alum, as chief compliance officer. Release

> Continuus Pharmaceuticals, which designs, builds and runs processes for the continuous manufacturing of small-molecule pharmaceuticals, and which grew from the collaboration between the Massachusetts Institute of Technology and Novartis ($NVS), has moved to Woburn, MA. Report

> A man with both U.K. and Pakistani citizenship has been indicted for operating websites that sold unapproved drugs that the sites claimed could cure a number of diseases. Release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.